Log in to save to my catalogue

Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulat...

Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulat...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8678141

Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA

About this item

Full title

Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA

Publisher

New York: Nature Publishing Group US

Journal title

Nature biotechnology, 2021-12, Vol.39 (12), p.1537-1547

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Circulating tumor-derived DNA (ctDNA) is an emerging biomarker for many cancers, but the limited sensitivity of current detection methods reduces its utility for diagnosing minimal residual disease. Here we describe phased variant enrichment and detection sequencing (PhasED-seq), a method that uses multiple somatic mutations in individual DNA fragm...

Alternative Titles

Full title

Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8678141

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8678141

Other Identifiers

ISSN

1087-0156

E-ISSN

1546-1696

DOI

10.1038/s41587-021-00981-w

How to access this item